loading

Werewolf Therapeutics Inc Stock (HOWL) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
50.57%
0.742
1.501 5.897 8.081 4.464
Operating Expenses
23.79%
17.90
14.46 15.15 14.15 16.69
Interest Income/Expense
1.003
- - - -
Benefits Costs and Expenses
25.41%
16.93
13.50 14.18 13.18 16.45
Costs And Expenses
23.79%
17.90
14.46 15.15 14.15 16.69
Operating Income/Loss
32.40%
-17.16
-12.96 -9.251 -6.067 -12.22
Nonoperating Income/Loss
1.04%
0.969
0.959 0.966 0.969 0.241
Income/Loss From Continuing Operations Before Tax
34.91%
-16.19
-12.00 -8.285 -5.098 -11.98
Income/Loss From Continuing Operations After Tax
34.91%
-16.19
-12.00 -8.285 -5.098 -11.98
Net Income/Loss
34.91%
-16.19
-12.00 -8.285 -5.098 -11.98
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
13,254%
41.61
0.3116 35.65 35.56 34.78
Diluted Average Shares
13,254%
41.61
0.3116 35.65 35.56 34.78
Basic Earnings Per Share
18.18%
-0.39
-0.33 -0.23 -0.14 -0.34
Diluted Earnings Per Share
18.18%
-0.39
-0.33 -0.23 -0.14 -0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):